U.S. markets open in 7 hours 44 minutes
  • S&P Futures

    4,171.75
    +14.00 (+0.34%)
     
  • Dow Futures

    34,372.00
    +116.00 (+0.34%)
     
  • Nasdaq Futures

    13,382.00
    +78.50 (+0.59%)
     
  • Russell 2000 Futures

    2,235.10
    +9.60 (+0.43%)
     
  • Crude Oil

    66.55
    +0.28 (+0.42%)
     
  • Gold

    1,870.30
    +2.70 (+0.14%)
     
  • Silver

    28.70
    +0.43 (+1.51%)
     
  • EUR/USD

    1.2170
    +0.0013 (+0.11%)
     
  • 10-Yr Bond

    1.6400
    0.0000 (0.00%)
     
  • Vix

    19.72
    +0.91 (+4.84%)
     
  • GBP/USD

    1.4170
    +0.0032 (+0.23%)
     
  • USD/JPY

    109.1680
    -0.0320 (-0.03%)
     
  • BTC-USD

    45,410.00
    +2,843.03 (+6.68%)
     
  • CMC Crypto 200

    1,264.92
    +67.00 (+5.59%)
     
  • FTSE 100

    7,032.85
    -10.76 (-0.15%)
     
  • Nikkei 225

    28,476.65
    +651.82 (+2.34%)
     

Mastercard (MA), Payoneer to Provide Digital Payments for B2B

  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.

Mastercard Inc. MA has been chosen by Payoneer Inc. to offer digital solutions to small and mid-sized businesses.

Both companies entered into a multifaceted relationship pursuant to which Payoneer Digital Purchasing Mastercard will be made available to SMBs, e-commerce sellers and freelancers worldwide. This digital card will be tailored to suit the need of these entities.

This joint offering is meant to serve the growing B2B market. This partnership is a perfect complement for both companies. Payoneer will access Mastercard’s innovative products and benefits to better serve its customers. Meanwhile, the latter will benefit from the global B2B footprint of the former, thereby gaining access to the company’s ecosystem of more than 5 million businesses.

Small and mid-scale entities for whom this service is intended will gain from an immediate access to the funds earned, enabling them to make purchases anywhere around the world where Mastercard is accepted. This apart, they can access multiple cards, thereby streamlining the expense management of businesses across platforms, storefronts and product lines. Besides, a virtual card access will provide SMBs with the choice of receiving and making payment as demand for digital payments continues to accelerate.

This deal reflects Mastercard’s intent to expand in the B2B digital payment space. The large market opportunity and lack of digitization in B2B payments unlock significant growth opportunities for the digital disruptors.
Digitization in the B2B payments space was already on track and the COVID-19 breakout only accelerated this transition. Given that most businesses are now in dire need of funds, speedy transfer of money between businesses via the digital mode in contrast to the earlier practice of B2B payments (which always involved longer processing times for payments) seems the need of the hour.

Per a new Juniper Research study, the total value of B2B cross-border payments is predicted to reach a value of $35 trillion in 2022 from a COVID-hit low of $27 trillion in 2020. Thus, it will take a couple of years’ time to achieve this 30% growth as the pandemic impact on the global economy has been devastating so far.

Other card networks, namely Visa Inc. V, American Express Co. AXP and Discover Financial Services DFS also stand to benefit from this increasing strength in the B2B digital payment market. Evidently, these companies remained active in the said space.

Mastercard has gained 17.6% in six months’ time compared with its industry’s growth of 12.92%.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>




Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

American Express Company (AXP) : Free Stock Analysis Report

Mastercard Incorporated (MA) : Free Stock Analysis Report

Visa Inc. (V) : Free Stock Analysis Report

Discover Financial Services (DFS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research